Diabetes Management System with Sensor Pen Cap for Automated Insulin Tracking

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Individuals with diabetes face challenges in accurately determining insulin doses due to cognitive burden and human error, leading to improper dosing, skipping, or doubling up on insulin injections, which can result in hyperglycemia or hypoglycemia.

Innovation Solution

A diabetes management system that includes a user interface for receiving user-specific dosage parameters, providing insulin therapy recommendations based on blood glucose data, meal size estimations, and other parameters, using a mobile application and pen cap accessories to simplify data entry and monitoring, and automatically capture insulin delivery data to minimize manual calculations and errors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If manual insulin dosing calculations are performed by the user, then the user can determine insulin doses, but cognitive burden and human error increase leading to improper dosing

Engineering Contradiction:
Improveinsulin dosing accuracyVSAvoidcognitive burden
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The system enables self-service by automatically capturing insulin delivery data through sensors that detect injection events, eliminating the need for manual dosing calculations and reducing cognitive burden while maintaining dosing accuracy

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

Manual mechanical calculation methods are replaced with electronic sensing and automated data capture systems that objectively measure and record insulin delivery parameters, reducing human error in dosing determination

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If multiple daily insulin injections are administered, then glycemic control can be maintained, but the complexity of self-monitoring and self-administration increases

Engineering Contradiction:
Improveglycemic controlVSAvoidtherapy management complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Multiple separate therapy management functions are merged into a single integrated system that combines glucose monitoring, insulin delivery tracking, and dosing recommendations into one unified platform, reducing overall therapy management complexity

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The system performs multiple functions including glucose level monitoring, insulin delivery detection, dosing calculation, and alert generation within a single multi-functional device, simplifying the management of multiple daily injections

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Ease of operation

If bolus calculators are used to assist with insulin dosing, then some mental calculations are removed, but data entry requirements and procedural burden remain

Engineering Contradiction:
Improvemental calculation burdenVSAvoiddata entry time
Core Design Contradiction:
Ease of operationVSLoss of time

Solution Approach 1:

The system performs automated data capture through sensors that detect insulin delivery events without requiring user data entry, eliminating the time burden of manual input while maintaining ease of operation

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system provides real-time feedback by automatically detecting insulin delivery parameters and immediately calculating recommended dosing adjustments, eliminating both mental calculation burden and data entry requirements

Inventive Principle:
Principle #23Feedback

Data Source

PatentEP4040443A1User interface for diabetes management systems and devices
Publication Date: 2022.08.10 BIGFOOT BIOMEDICAL INC
  • EP4040443A1 patent drawingFigure 1A
  • EP4040443A1 patent drawingFigure 1
  • EP4040443A1 patent drawingFigure 1C

AI summary

One or more embodiments of the disclosure relate, generally, to a diabetes management system. The diabetes management system may include a computing device that is configured to receive data relating to prior insulin use of a user and calculate a sliding scale glucose correction based, at least in part, on the data relating to prior insulin use.